Celyad Oncology SA
CLYYF
$0.25
-$0.10-28.57%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -53.88% | -57.22% | -86.10% | -87.29% | -43.83% |
| Total Receivables | -0.84% | -8.03% | -23.23% | -29.83% | -69.44% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -68.83% | -71.08% | -49.26% | -53.62% | -29.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,754.51% | 1,620.12% | 29.19% | 18.05% | -45.24% |
| Total Current Assets | -39.13% | -43.53% | -68.91% | -71.58% | -45.13% |
|
|
|||||
| Total Current Assets | -39.13% | -43.53% | -68.91% | -71.58% | -45.13% |
| Net Property, Plant & Equipment | -100.00% | -100.00% | -12.20% | -19.74% | -23.59% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -21.01% | -26.85% | -20.07% | -27.05% | -55.18% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -53.07% | -56.47% | -16.99% | -24.13% | -45.88% |
| Total Assets | -50.90% | -54.46% | -51.38% | -55.56% | -42.89% |
|
|
|||||
| Total Accounts Payable | -53.00% | -56.40% | -4.77% | -12.95% | -7.09% |
| Total Accrued Expenses | -3.99% | -10.95% | 22.03% | 11.55% | -16.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -45.57% | -50.24% | -14.73% |
| Total Finance Division Other Current Liabilities | 2.82% | -4.63% | 200.90% | 175.02% | -7.15% |
| Total Other Current Liabilities | 2.82% | -4.63% | 200.90% | 175.02% | -7.15% |
| Total Current Liabilities | -27.55% | -32.80% | 68.72% | 54.22% | -9.08% |
|
|
|||||
| Total Current Liabilities | -27.55% | -32.80% | 68.72% | 54.22% | -9.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -0.91% | -9.42% | -20.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -99.14% | -99.20% | -25.11% | -31.54% | -11.46% |
| Total Liabilities | -77.58% | -79.20% | 0.66% | -7.99% | -11.60% |
|
|
|||||
| Common Stock & APIC | 27.21% | 18.00% | 9.61% | 0.18% | -76.64% |
| Retained Earnings | -13.15% | -4.96% | -11.56% | -1.97% | 4.81% |
| Treasury Stock & Other | 13.44% | 5.23% | 9.63% | 0.21% | 0.66% |
| Total Common Equity | 440.68% | 401.51% | -204.10% | -195.15% | -92.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 440.68% | 401.51% | -204.10% | -195.15% | -92.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 440.68% | 401.51% | -204.10% | -195.15% | -92.41% |
|
|
|||||